Thus, although failing to completely cure stroke, EA pretreatment exerted neuroprotective effects against cerebral ischemic injury by promoting α7nAChR-mediated microglial phenotype conversion, suggesting a potential therapeutic target in the treatment of ischemic stroke. This evidence concerns the gene CHRNA7 and Stroke.